Not applicableStudy completedNCT06004102What this trial is testingMedication Adherence in Kidney TransplantWho this might be right forMedication Adherence Akdeniz University Hospital 100
Post-approval studies (Phase 4)Active Not RecruitingNCT05410496What this trial is testingTenofovir Alafenamide Switching Therapy in Kidney or Liver Transplant Recipients With Chronic HBV InfectionWho this might be right forSafety IssuesChronic Hepatitis BTransplant Recipient Taichung Veterans General Hospital 52
Large-scale testing (Phase 3)Study completedNCT00170833What this trial is testingSafety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant PatientsWho this might be right forRenal Transplantation Novartis Pharmaceuticals 80
Not applicableEnded earlyNCT00365833What this trial is testingCEC/EPC and Cardiovascular Risk in Renal Transplant RecipientsWho this might be right forTransplantation, KidneyCardiovascular AbnormalitiesCardiovascular Diseases University of Florida 8
Post-approval studies (Phase 4)Study completedNCT06044493What this trial is testingMYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant RecipientsWho this might be right forKidney Transplant Chong Kun Dang Pharmaceutical 158
Not applicableEnrolling By InvitationNCT06336863What this trial is testingUse of DNA Testing and Gene Expression Profiling to Help Transition Kidney Transplant Recipients to Belatacept-only ImmunosuppressionWho this might be right forKidney Transplant Immunosuppression University of Texas Southwestern Medical Center 24
Not applicableStudy completedNCT05465863What this trial is testingHumoral and Cellular İmmune Response to SARS-CoV-2 mRNA BNT162b2 Vaccine in Children With Chronic Kidney DiseasesWho this might be right forChronic Kidney Disease 5DChronic Kidney Disease 5T Istanbul University - Cerrahpasa 101
Post-approval studies (Phase 4)Ended earlyNCT00658333What this trial is testingA Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal SymptomsWho this might be right forRenal Transplantation Novartis Pharmaceuticals 30
Large-scale testing (Phase 3)Study completedNCT00720265What this trial is testingAssess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation PatientsWho this might be right forKidney Transplantation Astellas Pharma Inc 135
Large-scale testing (Phase 3)Study completedNCT01476488What this trial is testingConversion of Prograf to Advagraf in Pediatric Renal Transplant RecipientsWho this might be right forKidney TransplantationPediatric PatientsMaintenance With Tacrolimus Seoul National University Hospital
Not applicableUnknownNCT03120377What this trial is testingEfficiency of a Whole Body Vibration Training Program in Adult Renal Transplanted PatientsWho this might be right forKidney TransplantationExercise Universidade Federal de Pernambuco 20
Post-approval studies (Phase 4)Study completedNCT03979365What this trial is testingEnvarsus XR Compared to Immediate Release TacrolimusWho this might be right forKidney Transplant Recipients Mayo Clinic 261
Large-scale testing (Phase 3)Study completedNCT02118896What this trial is testingStudy to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a TransplantWho this might be right forHeart TransplantationLiver TransplantationKidney Transplantation Astellas Pharma Europe Ltd. 850
Testing effectiveness (Phase 2)Study completedNCT03629080What this trial is testingCMV Vaccine (HB-101) in Kidney Transplant PatientsWho this might be right forCytomegalovirus (CMV) InfectionKidney Transplantation Hookipa Biotech GmbH 83
Large-scale testing (Phase 3)WithdrawnNCT03596970What this trial is testingStudy of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients.Who this might be right forLiver Transplantation Novartis Pharmaceuticals
Post-approval studies (Phase 4)UnknownNCT00327483What this trial is testingWeb Based Renal Transplant Patient Medication EducationWho this might be right forRenal Transplant Recipients Agency for Healthcare Research and Quality (AHRQ) 250
Testing effectiveness (Phase 2)Study completedNCT01596062What this trial is testingPharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)Who this might be right forRenal Transplantation Novartis Pharmaceuticals 16
Not applicableStudy completedNCT02639949What this trial is testingMeasuring and Improving Medication Adherence in Kidney Transplant PatientsWho this might be right forKidney Transplant Recipients National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 45
Not applicableStudy completedNCT03794817What this trial is testingImmune Monitoring in Sensitized Patients at Risk of RejectionWho this might be right forKidney Failure University of California, San Francisco 112
Post-approval studies (Phase 4)Study completedNCT00652834What this trial is testingSmall Bowel Capsule Endoscopy Findings in Patients Receiving Cellcept®Who this might be right forGastrointestinal LesionsSigns and Symptoms, Digestive University of California, Los Angeles 23